Isabelle Camby

3.6k total citations · 1 hit paper
78 papers, 3.1k citations indexed

About

Isabelle Camby is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Isabelle Camby has authored 78 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 17 papers in Immunology and 14 papers in Genetics. Recurrent topics in Isabelle Camby's work include Galectins and Cancer Biology (15 papers), Glioma Diagnosis and Treatment (14 papers) and Signaling Pathways in Disease (11 papers). Isabelle Camby is often cited by papers focused on Galectins and Cancer Biology (15 papers), Glioma Diagnosis and Treatment (14 papers) and Signaling Pathways in Disease (11 papers). Isabelle Camby collaborates with scholars based in Belgium, France and Germany. Isabelle Camby's co-authors include Róbert Kiss, Marie Le Mercier, Florence Lefranc, Isabelle Salmon, Florence Lefranc, Christine Decaestecker, Hans‐Joachim Gabius, Francis Darro, Herbert Kaltner and Jacques Brotchi and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and Cancer Research.

In The Last Decade

Isabelle Camby

78 papers receiving 3.1k citations

Hit Papers

Galectin-1: a small protein with major functions 2006 2026 2012 2019 2006 200 400 600

Peers

Isabelle Camby
Julie Nardone United States
Haihua Gu China
Melania Capasso United Kingdom
Eli R. Zunder United States
Mariano J. Alvarez United States
Julie Nardone United States
Isabelle Camby
Citations per year, relative to Isabelle Camby Isabelle Camby (= 1×) peers Julie Nardone

Countries citing papers authored by Isabelle Camby

Since Specialization
Citations

This map shows the geographic impact of Isabelle Camby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Camby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Camby more than expected).

Fields of papers citing papers by Isabelle Camby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Camby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Camby. The network helps show where Isabelle Camby may publish in the future.

Co-authorship network of co-authors of Isabelle Camby

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Camby. A scholar is included among the top collaborators of Isabelle Camby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Camby. Isabelle Camby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ensign, Shannon P. Fortin, Marie Le Mercier, Isabelle Camby, et al.. (2008). Galectin‐1 Is Implicated in the Protein Kinase C ε/Vimentin‐Controlled Trafficking of Integrin‐β1 in Glioblastoma Cells. Brain Pathology. 20(1). 39–49. 54 indexed citations
2.
Saussez, Sven, Isabelle Camby, Gérard Toubeau, & Róbert Kiss. (2007). Galectins as modulators of tumor progression in head and neck squamous cell carcinomas. Head & Neck. 29(9). 874–884. 52 indexed citations
3.
Ingrassia, Laurent, Isabelle Camby, Florence Lefranc, et al.. (2006). Anti-Galectin Compounds as Potential Anti-Cancer Drugs. Current Medicinal Chemistry. 13(29). 3513–3527. 87 indexed citations
4.
Lefranc, Florence, Niloufar Sadeghi, Isabelle Camby, et al.. (2006). Present and potential future issues in glioblastoma treatment. Expert Review of Anticancer Therapy. 6(5). 719–732. 112 indexed citations
5.
Lefranc, Florence, Isabelle Camby, Nathalie Belot, et al.. (2002). Gastrin Significantly Modifies the Migratory Abilities of Experimental Glioma Cells. Laboratory Investigation. 82(9). 1241–1252. 20 indexed citations
7.
Darro, Francis, et al.. (1999). In vitro motility evaluation of aggregated cancer cells by means of automatic image processing. Cytometry. 36(1). 1–10. 25 indexed citations
8.
Camby, Isabelle, Nikoletta Nagy, Maria-Beatriz S. Lopes, et al.. (1999). Supratentorial Pilocytic Astrocytomas, Astrocytomas, Anaplastic Astrocytomas and Glioblastomas are Characterized by a Differential Expression of S100 Proteins. Brain Pathology. 9(1). 1–19. 100 indexed citations
9.
Gordower, Laurence, Christine Decaestecker, M. Beatriz S. Lopes, et al.. (1998). Determination of growth fraction and cell density to evaluate the potential growth of human oligodendroglial and astrocytic tumours. Journal of Cancer Research and Clinical Oncology. 124(8). 427–434. 1 indexed citations
10.
Camby, Isabelle, Francis Darro, Isabelle Migeotte, et al.. (1998). Gastrin inhibits motility, decreases cell death levels and increases proliferation in human glioblastoma cell lines. Journal of Neurobiology. 37(3). 373–382. 1 indexed citations
12.
Camby, Isabelle, Nikoletta Nagy, Thierry Gras, et al.. (1997). Influence of epidermal growth factor and gastrin on the cell proliferation of human meningiomas versus astrocytic tumors maintained as ex vivo tissue cultures. Neuropeptides. 31(3). 217–225. 5 indexed citations
13.
Decaestecker, Christine, M. Beatriz S. Lopes, Laurence Gordower, et al.. (1997). Quantitative Chromatin Pattern Description in Feulgen-stained Nuclei as a Diagnostic Tool to Characterize the Oligodendroglial and Astroglial Components in Mixed Oligo-astrocytomas. Journal of Neuropathology & Experimental Neurology. 56(4). 391–402. 13 indexed citations
14.
Decaestecker, Christine, Myriam Remmelink, Isabelle Salmon, et al.. (1996). Methodological aspects of using decision trees to characterise leiomyomatous tumors. Cytometry. 24(1). 83–92. 1 indexed citations
15.
Decaestecker, Christine, Myriam Remmelink, Isabelle Salmon, et al.. (1996). Methodological aspects of using decision trees to characterise leiomyomatous tumors. Cytometry. 24(1). 83–92. 18 indexed citations
17.
Camby, Isabelle, Isabelle Salmon, Andr� Danguy, Jean‐Lambert Pasteels, & Robert Kiss. (1995). The use of the digital cell image analysis of Feulgen-stained nuclei to detect apoptosis. Histochemistry and Cell Biology. 104(5). 407–414. 11 indexed citations
18.
Camby, Isabelle, Isabelle Salmon, Francis Darro, et al.. (1994). Characterization of the influence of 20 anti-hormone and/or anti-growth factor antibodies on the regulation of glioma cell proliferation in vitro. Journal of Neuro-Oncology. 21(2). 24. 2 indexed citations
19.
Camby, Isabelle, Robert Dedecker, André Danguy, et al.. (1994). Influence of culture media on the morphological differentiation of the PC‐3 and DUI45 prostatic neoplastic cell lines. The Prostate. 24(4). 187–196. 13 indexed citations
20.
Kiss, Róbert, Isabelle Salmon, Isabelle Camby, Sally L. Gras, & J L Pasteels. (1993). Characterization of factors in routine laboratory protocols that significantly influence the Feulgen reaction.. Journal of Histochemistry & Cytochemistry. 41(6). 935–945. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026